Clinical Trial Update: Efficacy of Ocrelizumab in Autoimmune Encephalitis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy of ocrelizumab in autoimmune encephalitis has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Autoimmune Encephalitis | Phase 2 | Status: TERMINATED | Results posted: 2021-10-19